ArticleCancers2025

The Impact of Progesterone Receptor Status on Survival Outcomes in Metastatic Breast Cancer Patients Treated with First-Line CDK4/6 Inhibitors.

Murad Guliyev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.